Understanding the role technology plays in advanced primary care to vulnerable populations is vital to ensure proper and timely diagnosis and treatment to improve healthcare outcomes for the patient. The purpose of this assignment is to evaluate one global burden of disease OR risk factor in the family population (pediatric, adult, or geriatric) and explore one current evidence-based technology use that can offer improvement of outcomes and access to the population chosen.
This assignment will focus on the following course student learning outcomes (CSLO):
- Generate knowledge from clinical practice to improve practice and patient outcomes (EOPSLO# 4, 9).
- Leads practice inquiry, individually or in partnership with others (EOPSLO# 2, 3, 4, 7).
- Translates research and other forms of knowledge to improve practice processes and outcomes (EOPSLO# 9).
- Evaluate the relationships among access, cost, quality, and safety and their influence on healthcare (EOPSLO# 3, 6, 9).
- Collaborates in planning for transitions across the continuum of care (EOPSLO# 2, 7).
- Integrates ethical principles in decision-making (EOPSLO# 6, 9).
- Integrates appropriate technologies for knowledge management to improve healthcare (EOPSLO# 5).
- Evaluate the effectiveness of the plan of care for the family, as well as the individual, and implement changes (EOPSLO# 8).
Instructions: Please choose one global burden of disease and one population (adult, pediatric, or geriatric). Once the population is chosen, find one evidence-based technology to help support the improvement of outcomes in the global burden of disease chosen.
You are to write a three-to-five-page paper in APA format 7th edition with the following sections and level 2 headings:
My Theme is Artificial pancreas systems ( closed- loop System) in diabetes type 2
Introduction:
Brief overview of the health of the population chosen
-Introduce the global burden of disease OR risk factor chosen
-Importance of improving the condition and its impact on quality of life
Body of the Paper
Global Burden of Disease Condition/Risk Factor
-Describe the disease OR risk factor chosen
-What signs/symptoms are identified in the patient that can be found?
-How is it diagnosed and treated?
Technology and Healthcare
-Describe the paradigm shift in healthcare related to technology
-Elaborate how technology can improve health outcomes in your population
Chosen Evidence-Based Technology Use in Disease or Risk Factor
-Describe and summarize the evidence-based technology identified that has been shown to improve the condition or Risk Factor for your patient population chosen.
-Compare and contrast the positives and negatives of using this technology use chosen.
Conclusion
-Recap points discussed in the paper
-Importance of advancements in technology
Optional Resources:
https://www.thelancet.com/gbd/summaries
https://www.healthdata.org/research-analysis/library/what-global-burden-disease-gbd
Full Answer Section
Introducing Type 2 Diabetes as a Global Burden of Disease
Type 2 diabetes is a chronic condition characterized by the body's inability to effectively use insulin, leading to high blood sugar levels. It affects hundreds of millions of adults worldwide, significantly impacting their health and well-being. Uncontrolled diabetes can lead to serious complications like heart disease, stroke, blindness, and kidney failure.
Importance of Improving Glycemic Control and Quality of Life
Maintaining good glycemic control (blood sugar control) is crucial for preventing complications and improving the quality of life for adults with type 2 diabetes. Traditionally, this has been achieved through a combination of lifestyle modifications, medications, and self-monitoring of blood glucose levels. However, managing diabetes effectively can be challenging, and many adults struggle to maintain optimal glycemic control.
Body of the Paper
Global Burden of Disease Condition: Type 2 Diabetes
Description of Type 2 Diabetes
Type 2 diabetes occurs when the body either doesn't produce enough insulin or becomes resistant to its effects. Insulin is a hormone that helps cells absorb glucose (sugar) from the bloodstream for energy. When insulin is deficient or ineffective, blood sugar levels rise, leading to various health problems.
Signs and Symptoms
Common signs and symptoms of type 2 diabetes include:
- Excessive thirst and urination
- Increased hunger
- Unexplained weight loss
- Fatigue
- Blurred vision
- Slow-healing wounds
Diagnosis and Treatment
Type 2 diabetes is typically diagnosed through blood tests that measure fasting blood sugar levels and hemoglobin A1c (HbA1c), which indicates average blood sugar control over the past 2-3 months. Treatment focuses on managing blood sugar levels through lifestyle changes like healthy eating, regular exercise, and weight management. Medications like oral medications or injectable insulin may also be prescribed.
Technology and Healthcare: A Paradigm Shift
Technological advancements have revolutionized healthcare delivery, offering innovative solutions for managing chronic conditions like type 2 diabetes. These technologies empower patients, improve access to care, and enhance data collection for better disease management.
Improving Health Outcomes in Adults with Type 2 Diabetes
Technology can improve health outcomes in adults with type 2 diabetes in several ways:
- Continuous Glucose Monitoring (CGM): These sensor devices provide real-time blood sugar data, allowing for better monitoring and adjustments to insulin therapy.
- Telemedicine: Virtual consultations with healthcare providers improve access to care and support, especially in remote areas.
- Mobile Health Apps: Educational apps can empower patients to learn about diabetes management, while others can track blood sugar data, medication use, and diet.
Chosen Evidence-Based Technology: Artificial Pancreas Systems (Closed-Loop Systems)
Description and Summary
Artificial pancreas systems (APS), also known as closed-loop systems, are a significant technological advancement in diabetes management. These devices combine a continuous glucose monitor (CGM) with an insulin pump to automate insulin delivery. The CGM sensor continuously transmits blood sugar data to the pump's algorithm, which calculates and delivers the appropriate insulin dose based on real-time needs. This mimics the function of a healthy pancreas, helping to maintain optimal blood sugar levels.
Positives and Negatives of Artificial Pancreas Systems
Positives:
- Improved glycemic control: Studies have shown that APS use leads to better blood sugar control compared to traditional methods.
- Reduced risk of complications: Improved glycemic control can reduce the risk of long-term complications associated with diabetes.
- Improved quality of life: APS can provide peace of mind and reduce the burden of constant blood sugar monitoring and insulin dose adjustments.
Negatives:
- Cost: APS technology can be expensive, and insurance coverage may vary.
- Device dependence: Reliance on the technology can be a concern, and malfunctions require immediate troubleshooting.
- User training: Effective use requires proper training and ongoing support for patients and caregivers.
Conclusion
Type 2 diabetes is a growing global burden of disease with significant health and economic consequences. Technological advancements like artificial pancreas systems offer a promising solution for improving glycemic control and quality of life for adults with type 2 diabetes. While some challenges regarding cost, user dependence, and training exist, the potential benefits of APS use highlight the importance of continuous advancements in diabetes management technology.
Sample Answer
My Theme: Artificial Pancreas Systems (Closed-Loop Systems) in Type 2 Diabetes
Introduction
Brief Overview of Adult Health
Globally, chronic diseases are the leading cause of death and disability, accounting for over 70% of all deaths (World Health Organization, 2023). Among these, diabetes mellitus (diabetes) is a significant public health concern with a growing prevalence. Adults are the most affected age group, with type 2 diabetes representing the majority of cases.